View Older Stories View More Recent Stories

Jul 5, 2022 07:00AM Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation
Jun 7, 2022 04:05PM Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro's HFX 10 kHz Therapy
May 31, 2022 04:05PM Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions
May 4, 2022 04:05PM Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
Apr 6, 2022 07:00AM Nevro to Report First Quarter 2022 Financial Results
Mar 7, 2022 04:05PM Nevro Announces Positive Medicare Coverage Update from Noridian for the Treatment of Painful Diabetic Neuropathy
Feb 23, 2022 04:05PM Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
Feb 18, 2022 07:00AM Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series
Feb 11, 2022 08:31AM Nevro (NVRO) Reports Publication of 12-Month Data from SENZA-NSRBP Trial
Feb 11, 2022 08:30AM Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Jan 31, 2022 07:00AM Nevro to Present at Citi's 2022 Virtual Healthcare Conference
Jan 26, 2022 04:05PM Nevro Named to 2022 Bloomberg Gender-Equality Index
Jan 25, 2022 07:01AM Nevro (NVRO) Responds to Approval of Metronic's painful diabetic neuropathy
Jan 25, 2022 07:00AM Nevro Responds to Competitor's Announcement of FDA Approval for Painful Diabetic Neuropathy
Jan 24, 2022 04:05PM Nevro to Report Fourth Quarter and Full-Year 2021 Financial Results
Jan 19, 2022 07:01AM Nevro (NVRO) Granted FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System
Jan 19, 2022 07:00AM Nevro Announces FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System for Treatment of Non-Surgical Refractory Back Pain (NSRBP)
Jan 18, 2022 07:06AM Nevro (NVRO) Presents Data Reinforcing Significant and Durable Benefits of Nevro's 10 kHz Therapy
Jan 18, 2022 07:00AM Clinical Data Presented at 2022 North American Neuromodulation Society (NANS) Annual Meeting Reinforce Significant and Durable Benefits of Nevro's 10 kHz Therapy
Jan 10, 2022 06:03AM Nevro (NVRO) Reports Prelim Q4 Results
Jan 10, 2022 06:00AM Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2021 Revenue
Jan 4, 2022 07:06AM Nevro (NVRO) Granted UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy
Jan 4, 2022 07:00AM Nevro Announces UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy
Dec 21, 2021 04:06PM Nevro (NVRO) Announces Settlement of IP Litigation with Nalu Medical
Dec 21, 2021 04:05PM Nevro Announces Settlement of IP Litigation with Nalu Medical
Dec 20, 2021 07:00AM CORRECTING AND REPLACING -- Nevro to Present at 40th Annual J.P. Morgan Healthcare Conference
Dec 13, 2021 07:00AM Nevro Announces Three Podium Presentations from SENZA-PDN and SENZA-NSRBP Clinical Trials Have Been Accepted for Late-Breaking Abstract Sessions at NANS 2022 Annual Meeting
Dec 10, 2021 07:00AM Nevro to Present at 40th Annual J.P. Morgan Healthcare Conference
Nov 30, 2021 07:00AM Nevro Announces Two Health Economic Poster Presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2021 Meeting
Nov 29, 2021 11:05AM Nevro Announces Three Important Clinical Data Publications for Treating Painful Diabetic Neuropathy with 10 kHz Therapy
Nov 8, 2021 04:05PM Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
Nov 2, 2021 05:36AM Nevro (NVRO) Infringed Two Boston Scientific Patents, Owes $20M
Nov 1, 2021 06:31PM Nevro Announces Update in Patent Litigation with Boston Scientific
Oct 25, 2021 06:00AM Nevro to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
Oct 11, 2021 06:00AM Nevro to Report Third Quarter 2021 Financial Results
Aug 31, 2021 04:08PM Nevro (NVRO) Appoints Sri Kosaraju to its Board
Aug 31, 2021 04:05PM Nevro Announces Director Appointment
Aug 26, 2021 06:00AM Nevro to Present at Baird 2021 Global Healthcare Conference
Aug 25, 2021 06:00AM Nevro to Present at Morgan Stanley 19th Annual Global Healthcare Conference
Aug 23, 2021 06:00AM Nevro to Present at Wells Fargo Virtual Healthcare Conference
Aug 4, 2021 04:05PM Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance
Jul 19, 2021 07:03AM Nevro (NVRO) Announces FDA Approval for Senza System for Chronic Pain Associated with PDN
Jul 19, 2021 07:00AM Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Jul 7, 2021 07:00AM Nevro to Report Second Quarter 2021 Financial Results
Jun 22, 2021 06:25AM Nevro (NVRO) Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions
Jun 22, 2021 06:00AM Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting
Jun 22, 2021 06:00AM Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions
Jun 14, 2021 07:00AM Nevro to Host Virtual Analyst & Investor Briefing
May 5, 2021 04:05PM Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance
Apr 27, 2021 07:00AM Nevro to Present at UBS Global Healthcare Virtual Conference
View More Recent Stories View Older Stories